Director/PDMR Shareholding
Plant Health Care PLC
31 January 2007
31 January 2007
Plant Health Care PLC ('Plant Health Care' or 'the Company')
Directors' Dealings
Directors' Exercise of Options
The Company was notified on 30 January 2007 that, on the same day, Dr Donald
Marx, a director of the Company, exercised options over 715,761 ordinary shares
of 1p each in the Company ('Ordinary Shares') at an exercise price of 37 pence
per Ordinary Share and options over 34,237 Ordinary Shares at an exercise price
of 71 pence per Ordinary Share. Accordingly, on 30 January 2007 Dr Marx
exercised a total of 749,998 options over Ordinary Shares.
The Company was notified on 30 January 2007 that, on the same day, Mr John
Brady, a Director of the Company, exercised options over 300,000 Ordinary Shares
at a price of 37 pence per Ordinary Share.
Directors' Dealings
The Company was notified on 30 January 2007 that, on the same day Dr Marx and Mr
Brady sold 900,000 Ordinary Shares and 300,000 Ordinary Shares respectively all
at a price of 225 pence per Ordinary Share. All of these 1.2 million Ordinary
Shares sold by Dr Marx and Mr Brady were as a result of the exercise of options
(described above), with the exception of 150,002 Ordinary Shares held by Dr
Marx.
Directors' Interests and Admission of Ordinary Shares
Following the exercise of options and share sales described above, the
beneficial interests of the directors in the Company's Ordinary Share capital
are set out below:
Name Ordinary Percentage of Share Options
Shareholding issued Ordinary
Share capital
Dr Albert Fischer 143,371 0.35% 225,000
John Brady Nil Nil 1,200,000
Walter Bratkowski Nil Nil 200,000
Dr Robert Chanson 135,166 0.33% 210,000
Thomas Isler 400,846 0.97% 202,500
Dr Donald Marx 428,813 1.04% 3,470
Samuel Wauchope 52,232 0.13% Nil
Application has been made for 1,049,998 Ordinary Shares being issued pursuant to
the exercise of options described above, to be admitted to trading on the London
Stock Exchange's AIM market for listed securities ('Admission'). Admission is
expected to occur on 5 February 2007. The New Shares will rank pari passu with
the Company's existing Ordinary Shares.
Following admission of the New Shares, the total issued share capital of the
Company will be 41,428,422 Ordinary Shares, all of which have voting rights.
The above figure (41,428,422) may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, Plant Health Care plc under
the FSA's Disclosure and Transparency Rules.
For further information:
Tavistock Comunications
Jeremy Carey/Matt Ridsdale
Tel: +44 20 7920 3150
Plant Health Care PLC
Andrew Wood, Company Secretary
Tel: +44 (0) 20 8866 5702
This information is provided by RNS
The company news service from the London Stock Exchange